484 related articles for article (PubMed ID: 11078620)
1. False negative sentinel node procedure established through palpation of the biopsy wound.
Tanis PJ; Nieweg OE; Merkus JW; Peterse JL; Kroon BB
Eur J Surg Oncol; 2000 Nov; 26(7):714-5. PubMed ID: 11078620
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
Zhang JG; Zhong L; Li CL
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
[No Abstract] [Full Text] [Related]
3. Value of the sentinel lymph node procedure in patients with large size breast cancer.
Lelievre L; Houvenaeghel G; Buttarelli M; Brenot-Rossi I; Huiart L; Tallet A; Tarpin C; Jacquemier J
Ann Surg Oncol; 2007 Feb; 14(2):621-6. PubMed ID: 17103062
[TBL] [Abstract][Full Text] [Related]
4. Isolated retromammary lymph node metastasis of breast cancer without axillary lymph node involvement: a case report with a false-negative sentinel lymph node biopsy.
Rokutanda N; Horiguchi J; Koibuchi Y; Nagaoka R; Sato A; Odawara H; Tokiniwa H; Iino Y; Hirato J; Takeyoshi I
Breast Cancer; 2009; 16(2):162-5. PubMed ID: 19242778
[TBL] [Abstract][Full Text] [Related]
5. Axillary regional recurrence after sentinel lymph node biopsy for breast cancer.
Rosing DK; Dauphine CE; Vargas MP; Gonzalez K; Burla M; Kaufmann P; Vargas HI
Am Surg; 2006 Oct; 72(10):939-42. PubMed ID: 17058740
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
[TBL] [Abstract][Full Text] [Related]
7. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration.
van der Ploeg IM; Kroon BB; Antonini N; Valdés Olmos RA; Rutgers EJ; Nieweg OE
Ann Surg Oncol; 2008 Apr; 15(4):1025-31. PubMed ID: 18219534
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
9. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
Specht MC; Fey JV; Borgen PI; Cody HS
J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914
[TBL] [Abstract][Full Text] [Related]
10. Sentinel node mapping for breast cancer: the operative experience of a breast surgeon in a rural community.
Davit FE; Gatmaitan P; Garguilo G
Am Surg; 2008 May; 74(5):423-7. PubMed ID: 18481500
[TBL] [Abstract][Full Text] [Related]
11. Preoperative lymphatic mapping does not predict the number of axillary sentinel lymph nodes identified during surgery in breast cancer patients.
Carmon M; Hain D; Shapira J; Golomb E
Breast J; 2006; 12(5):424-7. PubMed ID: 16958959
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of clinicopathological factors associated with false-negative rate of sentinel lymph node biopsy in breast cancer patients: experience of a single center].
Yang B; Zheng G; Zuo WS; Yang L; Wang YS; Zheng MZ; Liu YS; Yu ZY
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):389-93. PubMed ID: 24054019
[TBL] [Abstract][Full Text] [Related]
13. Axillary lymphectomy in breast cancer.
Barillari P; Leuzzi R; D'Angelo F; Bassiri-Gharb A; Naticchioni E
Minerva Chir; 2002 Apr; 57(2):129-33. PubMed ID: 11941288
[TBL] [Abstract][Full Text] [Related]
14. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
15. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection.
Roumen RM; Kuijt GP; Liem IH; van Beek MW
Br J Surg; 2001 Dec; 88(12):1639-43. PubMed ID: 11736979
[TBL] [Abstract][Full Text] [Related]
16. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
[TBL] [Abstract][Full Text] [Related]
18. [Application of methylene blue dye to sentinel lymph node biopsy in breast cancer and its influencing factors].
Huang XY; Wu J; Liu ZB; Zhang JX; Han QX; Xu WP; Ping B; Yang WT; Shen ZZ; Shao ZM
Ai Zheng; 2007 Oct; 26(10):1133-7. PubMed ID: 17927887
[TBL] [Abstract][Full Text] [Related]
19. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
20. Patients with breast cancer and positive sentinel nodes: axillary dissection or axillary radiotherapy?
Zippel D; Papa M
Arch Surg; 2003 Oct; 138(10):1159. PubMed ID: 14557139
[No Abstract] [Full Text] [Related]
[Next] [New Search]